HK Stock Market Move | JD INDUSTRIALS (07618) rises over 3% after signing a strategic cooperation agreement with AMD, focusing on deep integration of "industrial large models + intelligent computing hardware"
JD INDUSTRIALS (07618) rose over 3%, up 3.28% as of press time, at HK$12.9, with a turnover of HK$7.758 million.
JD INDUSTRIALS (07618) rose over 3%, up 3.28% as of press time, at HK$12.9, with a turnover of HK$7.758 million.
On the news front, according to JD INDUSTRIALS' official WeChat account, the company recently signed a strategic cooperation agreement with AMD at the main forum of the 26th China International Industry Fair held in Shanghai, to carry out multi-level, wide-ranging, and all-round deep strategic cooperation in areas such as industrial large models, intelligent computing power, global promotion of industrial scenario applications, and market channels. In particular, the two parties will focus on the deep integration of "industrial large models + intelligent computing hardware," targeting industrial terminal scenarios such as factories and workshops as well as edge computing environments, to jointly develop AI terminal products and applications for industrial sites.
According to the agreement, JD INDUSTRIALS' industrial large models will undergo adaptation and collaborative optimization with the AMD Ryzen AI Max series processors, targeting industrial terminal scenarios such as factories and workshops as well as edge computing environments, to jointly develop AI terminal products and applications for industrial sites; the two parties will carry out the definition, development, validation, and benchmark implementation of joint solutions in typical industrial scenarios such as smart manufacturing, predictive equipment maintenance, industrial visual quality inspection, safety production patrol inspection, and intelligent scheduling and supply chain collaboration, achieving integrated deployment and large-scale commercialization of industrial large models at the end-side edge.
Related Articles

BUTONG GROUP (06090) repurchased 110,000 shares for HK$3.8656 million on October 15.

LEADS BIOLABS-B(09887): First Patient Dosed in Phase IB/II Clinical Trial of Vilixin (Opatilimab, PD-L1/41BB Bispecific Antibody) in Combination Therapy for Metastatic Colorectal Cancer

AI hot money flows to upstream miners: Tech giants want to "take stakes" in Anglo American, BHP Group Ltd Sponsored American Depositary Receipt Repr 2 Shs(BHP.US) and other mining companies to lock in copper supply.
BUTONG GROUP (06090) repurchased 110,000 shares for HK$3.8656 million on October 15.

LEADS BIOLABS-B(09887): First Patient Dosed in Phase IB/II Clinical Trial of Vilixin (Opatilimab, PD-L1/41BB Bispecific Antibody) in Combination Therapy for Metastatic Colorectal Cancer

AI hot money flows to upstream miners: Tech giants want to "take stakes" in Anglo American, BHP Group Ltd Sponsored American Depositary Receipt Repr 2 Shs(BHP.US) and other mining companies to lock in copper supply.






